(CALM) Cal-Maine Foods - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1280302027
Stock: Shell Eggs, Specialty Eggs, Egg Products, Prepared Foods
Total Rating 45
Risk 84
Buy Signal -1.91
| Risk 5d forecast | |
|---|---|
| Volatility | 37.3% |
| Relative Tail Risk | -5.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.08 |
| Alpha | -11.45 |
| Character TTM | |
|---|---|
| Beta | 0.214 |
| Beta Downside | 0.797 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.00% |
| CAGR/Max DD | 0.56 |
EPS (Earnings per Share)
Revenue
Description: CALM Cal-Maine Foods March 01, 2026
Cal-Maine Foods, Inc. (NASDAQ: CALM) is the largest U.S. producer and distributor of shell eggs and egg-based products, offering a range from conventional eggs to specialty lines such as cage-free, organic, and pasture-raised under brands like Egg-Land’s Best and 4-Grain. The company also markets ready-to-eat items (hard-cooked eggs, egg wraps, protein pancakes) and ancillary products such as feed and by-products, serving grocery chains, club stores, food-service distributors, and consumers across most U.S. regions and Puerto Rico.
Key recent metrics: Q4 2025 revenue rose 6.2% YoY to $1.09 billion, driven by a 9% price uplift in specialty eggs amid rising consumer demand for protein-rich, clean-label foods; EBITDA margin improved to 13.4% as feed-cost inflation eased to a 3-year low of 2.1% YoY. The broader packaged foods sector is benefiting from sustained discretionary spending and a 4-quarter trend of higher egg prices, which have risen ~5% year-over-year, supporting revenue growth for large producers.
For a deeper dive, check out ValueRay’s analysis of CALM.
Headlines to watch out for
- Egg prices directly impact revenue and profitability
- Feed costs, especially corn and soybean, affect margins
- Avian influenza outbreaks disrupt supply and raise costs
- Consumer demand for specialty eggs drives sales growth
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.37 > 0.02 and ΔFCF/TA 18.38 > 1.0 |
| NWC/Revenue: 36.45% < 20% (prev 37.73%; Δ -1.29% < -1%) |
| CFO/TA 0.43 > 3% & CFO 1.36b > Net Income 1.15b |
| Net Debt (-369.4m) to EBITDA (1.64b): -0.23 < 3 |
| Current Ratio: 8.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.2m) vs 12m ago -1.64% < -2% |
| Gross Margin: 41.92% > 18% (prev 0.33%; Δ 4.16k% > 0.5%) |
| Asset Turnover: 149.6% > 50% (prev 123.9%; Δ 25.70% > 0%) |
| Interest Coverage Ratio: 3.04k > 6 (EBITDA TTM 1.64b / Interest Expense TTM 506k) |
Altman Z'' 10.00
| A: 0.49 (Total Current Assets 1.75b - Total Current Liabilities 218.8m) / Total Assets 3.14b |
| B: 0.88 (Retained Earnings 2.77b / Total Assets 3.14b) |
| C: 0.55 (EBIT TTM 1.54b / Avg Total Assets 2.82b) |
| D: 6.21 (Book Value of Equity 2.77b / Total Liabilities 446.3m) |
| Altman-Z'' Score: 16.26 = AAA |
Beneish M -3.06
| DSRI: 0.60 (Receivables 262.4m/317.8m, Revenue 4.21b/3.08b) |
| GMI: 0.78 (GM 41.92% / 32.69%) |
| AQI: 1.51 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 1.37 (Revenue 4.21b / 3.08b) |
| TATA: -0.07 (NI 1.15b - CFO 1.36b) / TA 3.14b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of CALM shares?
As of March 22, 2026, the stock is trading at USD 78.35 with a total of 2,601,824 shares traded.
Over the past week, the price has changed by -10.81%, over one month by -6.51%, over three months by -5.18% and over the past year by -4.07%.
Over the past week, the price has changed by -10.81%, over one month by -6.51%, over three months by -5.18% and over the past year by -4.07%.
Is CALM a buy, sell or hold?
Cal-Maine Foods has received a consensus analysts rating of 3.67.
Therefor, it is recommend to hold CALM.
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CALM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.8 | 12% |
| Analysts Target Price | 87.8 | 12% |
CALM Fundamental Data Overview March 22, 2026
P/E Trailing = 3.7114
P/E Forward = 19.802
P/S = 0.9936
P/B = 1.5551
P/EG = 2.1983
Revenue TTM = 4.21b USD
EBIT TTM = 1.54b USD
EBITDA TTM = 1.64b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -369.4m USD (from netDebt column, last quarter)
Enterprise Value = 3.05b USD (4.19b + (null Debt) - CCE 1.14b)
Interest Coverage Ratio = 3.04k (Ebit TTM 1.54b / Interest Expense TTM 506k)
EV/FCF = 2.60x (Enterprise Value 3.05b / FCF TTM 1.17b)
FCF Yield = 38.48% (FCF TTM 1.17b / Enterprise Value 3.05b)
FCF Margin = 27.83% (FCF TTM 1.17b / Revenue TTM 4.21b)
Net Margin = 27.37% (Net Income TTM 1.15b / Revenue TTM 4.21b)
Gross Margin = 41.92% ((Revenue TTM 4.21b - Cost of Revenue TTM 2.45b) / Revenue TTM)
Gross Margin QoQ = 26.95% (prev 33.74%)
Tobins Q-Ratio = 0.97 (Enterprise Value 3.05b / Total Assets 3.14b)
Interest Expense / Debt = unknown (Interest Expense 201k / Debt none)
Taxrate = 24.36% (33.2m / 136.1m)
NOPAT = 1.16b (EBIT 1.54b * (1 - 24.36%))
Current Ratio = 8.02 (Total Current Assets 1.75b / Total Current Liabilities 218.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.23 (Net Debt -369.4m / EBITDA 1.64b)
Debt / FCF = -0.32 (Net Debt -369.4m / FCF TTM 1.17b)
Total Stockholder Equity = 2.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 40.93% (Net Income 1.15b / Total Assets 3.14b)
RoE = 44.65% (Net Income TTM 1.15b / Total Stockholder Equity 2.58b)
RoCE = 52.64% (EBIT 1.54b / Capital Employed (Total Assets 3.14b - Current Liab 218.8m))
RoIC = 45.09% (NOPAT 1.16b / Invested Capital 2.58b)
WACC = 6.70% (E(4.19b)/V(4.19b) * Re(6.70%) + (debt-free company))
Discount Rate = 6.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.72%
[DCF] Terminal Value 85.62% ; FCFF base≈892.0m ; Y1≈1.10b ; Y5≈1.87b
[DCF] Fair Price = 907.0 (EV 42.85b - Net Debt -369.4m = Equity 43.22b / Shares 47.7m; r=6.70% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 0.48 | EPS CAGR: -46.04% | SUE: -1.56 | # QB: 0
Revenue Correlation: 57.69 | Revenue CAGR: 13.57% | SUE: -0.53 | # QB: 0
EPS current Year (2026-05-31): EPS=7.79 | Chg7d=+0.000 | Chg30d=-2.260 | Revisions Net=-1 | Growth EPS=-68.9% | Growth Revenue=-29.9%
EPS next Year (2027-05-31): EPS=3.88 | Chg7d=+0.000 | Chg30d=-1.790 | Revisions Net=-1 | Growth EPS=-50.2% | Growth Revenue=-8.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -19.0% (Discount Rate 7.9% - Earnings Yield 26.9%)
[Growth] Growth Spread = +10.9% (Analyst -8.1% - Implied -19.0%)
P/E Forward = 19.802
P/S = 0.9936
P/B = 1.5551
P/EG = 2.1983
Revenue TTM = 4.21b USD
EBIT TTM = 1.54b USD
EBITDA TTM = 1.64b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -369.4m USD (from netDebt column, last quarter)
Enterprise Value = 3.05b USD (4.19b + (null Debt) - CCE 1.14b)
Interest Coverage Ratio = 3.04k (Ebit TTM 1.54b / Interest Expense TTM 506k)
EV/FCF = 2.60x (Enterprise Value 3.05b / FCF TTM 1.17b)
FCF Yield = 38.48% (FCF TTM 1.17b / Enterprise Value 3.05b)
FCF Margin = 27.83% (FCF TTM 1.17b / Revenue TTM 4.21b)
Net Margin = 27.37% (Net Income TTM 1.15b / Revenue TTM 4.21b)
Gross Margin = 41.92% ((Revenue TTM 4.21b - Cost of Revenue TTM 2.45b) / Revenue TTM)
Gross Margin QoQ = 26.95% (prev 33.74%)
Tobins Q-Ratio = 0.97 (Enterprise Value 3.05b / Total Assets 3.14b)
Interest Expense / Debt = unknown (Interest Expense 201k / Debt none)
Taxrate = 24.36% (33.2m / 136.1m)
NOPAT = 1.16b (EBIT 1.54b * (1 - 24.36%))
Current Ratio = 8.02 (Total Current Assets 1.75b / Total Current Liabilities 218.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.23 (Net Debt -369.4m / EBITDA 1.64b)
Debt / FCF = -0.32 (Net Debt -369.4m / FCF TTM 1.17b)
Total Stockholder Equity = 2.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 40.93% (Net Income 1.15b / Total Assets 3.14b)
RoE = 44.65% (Net Income TTM 1.15b / Total Stockholder Equity 2.58b)
RoCE = 52.64% (EBIT 1.54b / Capital Employed (Total Assets 3.14b - Current Liab 218.8m))
RoIC = 45.09% (NOPAT 1.16b / Invested Capital 2.58b)
WACC = 6.70% (E(4.19b)/V(4.19b) * Re(6.70%) + (debt-free company))
Discount Rate = 6.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.72%
[DCF] Terminal Value 85.62% ; FCFF base≈892.0m ; Y1≈1.10b ; Y5≈1.87b
[DCF] Fair Price = 907.0 (EV 42.85b - Net Debt -369.4m = Equity 43.22b / Shares 47.7m; r=6.70% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 0.48 | EPS CAGR: -46.04% | SUE: -1.56 | # QB: 0
Revenue Correlation: 57.69 | Revenue CAGR: 13.57% | SUE: -0.53 | # QB: 0
EPS current Year (2026-05-31): EPS=7.79 | Chg7d=+0.000 | Chg30d=-2.260 | Revisions Net=-1 | Growth EPS=-68.9% | Growth Revenue=-29.9%
EPS next Year (2027-05-31): EPS=3.88 | Chg7d=+0.000 | Chg30d=-1.790 | Revisions Net=-1 | Growth EPS=-50.2% | Growth Revenue=-8.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -19.0% (Discount Rate 7.9% - Earnings Yield 26.9%)
[Growth] Growth Spread = +10.9% (Analyst -8.1% - Implied -19.0%)